ValuationViz

VKTX fund manager activity

Viking Therapeutics, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q1 2023 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalSold out——0.00%Aug 14, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed230,737$9,001,0500.02%Aug 14, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalTrimmed125,486$4,083,3140.01%May 15, 2026
Joel Greenblatt - Gotham Asset ManagementAdded260,778$8,485,7160.03%May 15, 2026

Older quarters